Latest News & Updates
Breaking News
3 hours ago
Pharma Now Editorial Team
Safic-Alcan Acquires Majority Stake in SA Ingredients to Deepen India Pharma Supply Reach
Pharma Now Editorial Team
Neuland Labs Signs Partnership with LIR Life for Transdermal GLP-1 Obesity Therapy Platform
Pharma Now Editorial Team
Roche Acquires PathAI in $750 Million Deal to Expand AI-Driven Companion Diagnostics
Pharma Now Editorial Team
Zealand Pharma Advances Petrelintide to Phase 3 After Positive ZUPREME-1 Results in Obesity Program
Pharma Now Editorial Team
Other trending news you may like to read
Bayer Acquires Perfuse Therapeutics in $2.45 Billion Deal for Ocular Pipeline Asset PER-001
Bayer acquires Perfuse Therapeutics for $2.45B, gaining Phase II ocular asset PER-001 for glaucoma and diabetic retinopathy.
Pharma Now Editorial Team
Safic-Alcan Acquires Majority Stake in SA Ingredients to Deepen India Pharma Supply Reach
Safic-Alcan acquires majority stake in SA Ingredients, reshaping excipient distribution across India's GMP pharma supply chain.
Pharma Now Editorial Team
Neuland Labs Signs Partnership with LIR Life for Transdermal GLP-1 Obesity Therapy Platform
Neuland Labs partners with LIR Life to develop a patch-based transdermal delivery platform for GLP-1 obesity therapies.
Pharma Now Editorial Team
Roche Acquires PathAI in $750 Million Deal to Expand AI-Driven Companion Diagnostics
Roche acquires PathAI for $750M upfront to integrate AI pathology tools into companion diagnostics and clinical trial workflows.
Pharma Now Editorial Team
